Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study

Fig. 2

Mean (SE) laboratory variables of interest over time. Including total cholesterol (a), LDL (b), lymphocyte counts (c), and neutrophil counts (d). Baseline qualifying index study data were used for approximately 90% of patients. Data for 12-month intervals are reported in the tables. Database lock: March 2, 2017. BID twice daily, BL baseline, LDL low-density cholesterol, SE standard error

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us